From Sugary Drinks to Red Wine: How Your Beverage Choices Affect Brain Health

CMS Launches New Dementia Care Management Program

New Drug Donanemab Shows Promise: Advancements in Early Alzheimer’s Treatment

White Paper on cost implications of Leqembi and other anti-amyloid drugs for payers and ACOs and options for utilization management

Introducing Leqembi: What You Need to Know About This Breakthrough in the Fight Against Alzheimer’s Disease

FAQ About Leqembi

Leqembi – Implications for Health Insurance Payers: A Comprehensive Analysis

The Power of Early Detection: Transforming Lives for Those Living with Frontotemporal Dementia

Insights on former First Lady, Rosalynn Carter’s Diagnosis

Promising Breakthrough in Alzheimer’s Treatment: Donanemab Study Results

Brain Training Games: Do They Actually Work?

Cognitive-Behavioral Therapy: A Powerful Tool for Memory Loss and Cognitive Symptoms